Member Contact: Keith McLean
Industry: Academic Research Organisation
At CSIRO, not only are we working closely with Australian biomedical companies to secure and further their competitive advantage, we’re helping to create them. Many of our technologies have been turned into spin-out companies and are transforming healthcare around the globe.
We work with around 100 Australian and international customers each year in the biotech, pharma and medtech sectors. Through these partnerships, we help companies capture new business opportunities and produce quality niche biomedical products using more sustainable, cost-competitive processes.
Using our leading science and technical expertise, we’re working on next generation therapies to treat diseases, advanced medical materials and drug discovery and delivery. Our core area of expertise and track record is in the creation of Food and Drug Administration (FDA) approved polymers and coatings for implantable and diagnostic applications.
We have state-of-the art high throughput equipment for the design, synthesis and biological testing of materials. We also specialise in polymer processing, 3D printing of titanium, surface engineering and prototyping of devices. We apply our expertise to targeted drug delivery, regenerative medicine, endoscopy products, remote monitoring, point-of-care diagnostics and to the finalisation of improved products within current FDA approvals.
For more information go to http://www.csiro.au/en/Research/MF